UA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
UA is not a good buy right now for an impatient investor. Despite a short-term uptrend in moving averages, momentum is weakening (MACD histogram negative and expanding), the statistical pattern outlook skews bearish over the next week/month, and the latest quarter shows deteriorating fundamentals (revenue down YoY and a swing to a loss). With earnings coming soon (2026-02-06 pre-market), the risk/reward favors avoiding new entries here; if you already own it, this setup argues for trimming/exiting rather than adding.
Trend/levels: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting the broader trend has improved. However, momentum is fading: MACD histogram is below zero (-0.0095) and negatively expanding (bearish momentum building). RSI(6)=62.2 is neutral-to-slightly-warm, not an oversold bounce setup. Key levels: Pivot 5.952 (near-term support). Resistance R1 6.311 then R2 6.533; price (~6.07 post-market) sits below the first resistance, implying limited immediate upside unless it reclaims >6.31 convincingly. Pattern-based outlook provided: ~30% chance of -0.9% next day, -4.47% next week, -6.34% next month, which reinforces a cautious/negative near-term bias.
Intellectia Proprietary Trading Signals
Options market is positioned bullish (very low put/call ratios) and volume/OI are elevated, which can support near-term squeezes/rallies.
Analyst commentary includes a constructive turnaround narrative (UBS) and brand strength arguments.
Technical backdrop still shows bullish moving-average stack, so a clean break above ~6.31 (R
could trigger momentum buying.
Upcoming earnings (2026-02-06 pre-market) can act as a catalyst if results/guide surprise positively.
Fundamentals deteriorated in the latest reported quarter (2026/Q2): revenue -4.69% YoY, EPS -0.04 (down 110% YoY), net income swung further negative, and gross margin fell (47.29, down ~4.96% YoY).
Momentum is weakening despite the MA uptrend (MACD histogram negative and worsening).
Pattern-based probabilities provided lean to downside over the next week/month.
Earnings on 2026-02-06 adds binary risk; with elevated IV, the market is already pricing a big move.
No supportive news flow in the last week to reinforce the bullish options positioning.
Latest quarter: 2026/Q2. Revenue was $1.333B (-4.69% YoY), indicating ongoing top-line contraction. Profitability weakened materially: net income -$18.8M (down -111.04% YoY) and EPS -0.04 (down -110.26% YoY), showing a swing to losses versus the prior year period. Gross margin declined to 47.29% (down -4.96% YoY), suggesting increased pressure from discounting/input costs/channel mix—overall a negative growth/quality trend into the next earnings print (2026-02-06 pre-market).
Recent trend: mixed but modestly improving tone. UBS (2026-01-02) reiterated Buy with an $8 PT, framing UA as a turnaround with potential multi-year earnings growth and undervalued brand equity. Baird (2026-01-07) named UA a Fresh Pick but kept a Neutral rating and $7 PT (constructive interest but not a full bullish call). Wall Street pros/cons summary: Pros—brand recognition, turnaround optionality, and improving North America trajectory could re-rate the stock. Cons—recent quarter shows shrinking revenue, margin pressure, and losses, which undermines the turnaround timeline; near-term technical momentum is weakening. Trading behavior checks: Hedge funds neutral (no strong recent trend), insiders neutral (no strong recent trend), and no recent Congress trading data available; no politician/influential-figure buy/sell signals were provided.
